Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rossi Christina Insider Profile
4 Followers
Rossi Christina, CCO at Blueprint Medicines, holds 20.02K shares in Blueprint Medicines (Ticker: BPMC). Most recently, Rossi Christina Sold $345 shares of Blueprint Medicines on Nov 05, 2020 for an estimated value of 34.39K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-55.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Rossi Christina's holdings
Insider Roles
CCO
Roles that Rossi Christina holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 05, 2020 - Nov 05, 2021
Return:-5.60%
The most profitable trade made by Rossi Christina
Rossi Christina's Trading History
List of latest transactions for each holding click on a transaction to see Rossi Christina's performance on stock
You May Also Like
Rossi Christina insider profile FAQ
What is the percentage of profitable transactions made by Rossi Christina?
The percentage of profitable transactions made by Rossi Christina is 0%.
What is the average return per transaction made by Rossi Christina?
The average return per transaction made by Rossi Christina is -55.10%.
What stocks does Rossi Christina hold?
Rossi Christina holds: BPMC stocks.
What was Rossi Christina’s latest transaction?
Rossi Christina latest transaction was an Informative Sell of $34.39K.
What was Rossi Christina's most profitable transaction?
Rossi Christina’s most profitable transaction was an Informative Sell of BPMC stock on November 5, 2020. The return on the trade was -5.60%.
What is Rossi Christina's role in Blueprint Medicines?
Rossi Christina's role in Blueprint Medicines is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.